Browsing Category
Healthcare Industry News
2467 posts
Imricor Medical (ASX: IMR) moves closer to US market with Advantage-MR regulatory filing
Imricor Medical Systems has filed Advantage-MR for FDA 510(k) clearance. Find out how this could reshape MRI-guided cardiac ablation workflows.
Careteq (ASX: CTQ) to divest Embedded Health Solutions for A$5m to stabilise balance sheet
Careteq Limited to sell Embedded Health Solutions for A$5 million, resetting strategy, balance sheet priorities, and ASX compliance risk. Find out what happens next.
Frontage Laboratories adds oncology and radiolabeled capacity to Secaucus Phase I unit for integrated CRDMO execution
Frontage Laboratories expands early-phase clinical research in U.S. and China. Find out how its oncology and AME focus could reshape sponsor strategies.
Can UnitedHealth bounce back after CMS’s reimbursement shock blindsides investors?
UnitedHealth’s stock plunge after CMS’s Medicare rate proposal has rattled markets. Find out what triggered the selloff and what’s next for UNH.
What do Peloton’s mass layoffs really signal about the future of at-home fitness?
Peloton is laying off 11% of its workforce in a major reset. Find out what this move means for its survival, investor sentiment, and fitness industry shifts.
Behind the CFO change: Will NuGen Medical now control its burn and unlock real growth?
NuGen Medical names Ajay Mishra as CFO to guide commercialization strategy. Find out what this move means for the company’s financial future and investor outlook.
MPS Limited (NSE: MPSLTD) acquires Unbound Medicine to deepen platform expansion into AI-powered healthcare learning
MPS Limited acquires Unbound Medicine for $16.5M, entering AI-driven healthcare learning. Find out what this strategic pivot means for its platform future.
What Neogen’s HYCOAT recall means for equine practitioners and FDA oversight expectations
Neogen’s HYCOAT recall reveals sterility failures in veterinary injectables. Find out what this means for equine care, regulators, and product oversight.
Vivian Health transitions CEO role to Bill Kong as AI marketplace strategy gains traction
Vivian Health names Bill Kong CEO as it enters a new AI-driven growth phase. Find out what this leadership change means for its business, strategy, and IAC.
GRAIL (Nasdaq: GRAL) files FDA application for Galleri test, aiming to redefine how cancer is detected in asymptomatic patients
GRAIL files FDA approval for Galleri, its blood-based test for early cancer detection. Find out what it means for diagnostics, payers, and public health.